The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…
BMI View: Mauritius' pharmaceutical and healthcare markets are expected to continue on a positive
growth trajectory over the forecast period. Meanwhile, Mauritius' 2016-2017 Budget is set to strengthen
manufacturing capacity in the pharmaceutical sector, including through the creation of a Pharmaceutical
Village at Rose Belle and several incentives for investors. Although revenue-earning potential from these
development initiatives will take time to materialise, Mauritius will continue to strengthen its international
reach, while gradually building its position as a research and manufacturing hub. This is illustrated by
Mauritius' growing integration with the rapidly growing economies of the East African Community, among
Headline Expenditure Projections
Pharmaceuticals: MUR6.17bn (USD176mn) in 2015 to MUR6.52bn (USD182mn) in 2016; +5.7% in local
currency terms and +3.4% in US dollar terms. Forecast revised downwards from last quarter.
Healthcare: MUR19.88bn (USD566mn) in 2015 to MUR21.05bn (USD586mn) in 2016; +5.9% growth in
local currency terms, and +3.6% in US dollar terms. Forecast revised downwards from last quarter.